RGEN

RGEN

Repligen Corp
Life Sciences Tools & Services
$181.62 +0.28% As of Aug 25, 12:41 AM
Loading chart...
Interactive chart powered by TradingView

Technical Analysis

Technical Caution: RGEN Overbought Near $181.62

Bearish
Aug 25, 2026 at 12:41 AM $181.62 (+0.28%)

Shares of Repligen Corp (RGEN) rose 0.28% to $181.62 on August 25.

From a technical standpoint, the outlook appears bullish:

Moving Averages Bullish EMA alignment intact with price above the 9-day at $173.45 and 21-day at $163.67.
Momentum RSI at 76.8 is in overbought territory, suggesting potential near-term exhaustion. MACD reads 9.88 against its 8.18 signal line (bullish).
Volatility Bollinger Band width at 31.9% indicates normal volatility.

While the trend remains bullish, elevated RSI warrants caution for new entries at current levels.

Technical levels: $135.88 support, $187.37 resistance.

Sell Signal? RGEN RSI Peaks at $181.62

Bearish
Aug 24, 2026 at 9:01 PM $181.62 (+0.28%)

Momentum Fatigue: RGEN Extended at $181.13

Bearish
Aug 23, 2026 at 6:41 AM $181.13 (+0.47%)

Momentum Fatigue: RGEN Extended at $181.13

Bearish
Aug 22, 2026 at 1:34 AM $181.13 (+0.47%)

Pullback Risk Rising for RGEN at $181.13

Bearish
Aug 21, 2026 at 9:01 PM $181.13 (+0.47%)
Systematic technical analysis • Updated daily after market close
Exclusive Offer

Get Trade Alerts

Receive disciplined options trade ideas with entries, targets & risk management.

Use code:
HEADSTART50
50% off your first month

Market Summary

Current Price $181.62
Daily Change +0.28%
Sentiment Bearish
Sector Life Sciences Tools & Services
Last Updated Aug 25
Disclaimer: This analysis is for educational purposes only. Options trading involves substantial risk. Past performance does not guarantee future results.